MetaCap

Larimar Therapeutics Statistics

NASDAQ: LRMRHealth CareBiotechnology: Pharmaceutical PreparationsUSD

3.14-0.08 (-2.48%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Larimar Therapeutics by the numbers

Larimar Therapeutics has a market capitalization of $328.6 million based on 104.63M shares outstanding. With trailing EPS of $-1.67, Larimar Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 10.0% above its 50-day average and 16.5% below its 200-day average.

Average daily trading volume is 1.38M shares, or about $4.3 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

LRMR valuation vs. peer median

LRMR compared with the median of 8 peer companies
MetricLRMRPeer medianDifference
Market cap$328.55M$335.47M-2%
Avg. volume1.38M617.37K+124%

Peer median across 8 companies: INO, MPLT, AVIR, CTNM, PEPG, SPRY, ASPE, PBYI.

Valuation

Price and trading

Previous close
3.22
Open
3.15
Day range
2.96 – 3.22
52-week range
1.92 – 6.42
52-week change
-11.80%
Beta
—
Volume
1.71M

Dividends and events

Annual dividend
None
Next earnings date
Nov 16, 2026

Additional statistics

Market Cap
328.55M
Forward Pe
-3.47
Eps
-1.67
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
6.42
Week52 Low
1.92
Avg Volume
1.38M
Shares Outstanding
104.63M
Ma50
2.85
Ma200
3.76
Earnings Date
Nov 16, 2026
Pct From52w High
-51.09%
Pct From52w Low
63.97%

Related